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Dear Sir,
Cerebrotendinous xanthomatosis (CTX) is a rare autosomal
recessive lipid storage disease with deposition of cholesta-
nol in many tissues causing both systemic and neurological
involvement. CTX is due to mutations in the CYP27A1 gene
leading to defective activity of sterol 27-hydroxylase. Ther-
apy with chenodeoxycholic acid (CDCA) normalizes bile
acids synthesis and prevents clinical deterioration. Brain
magnetic resonance imaging (MRI) typically includes den-
tate nuclei hyperintensities on T2-weighted and FLAIR
sequences, and has been reported to be substantially stable
after treatment with CDCA [1, 2].
We report on a 33-year-old woman with gait unsteadiness
since the age of 30 years. Her history revealed mental
retardation, diarrhea and cataracts. Clinical examination dis-
closed dysarthria and ataxia. Tendon xanthomas were ab-
sent. Biochemical analysis revealed elevated plasma levels
of cholestanol and 7α-hydroxy-4-cholesten-3-one, and de-
creased 27-hydroxycholesterol (27OHC) concentration.
CYP27A1 gene analysis uncovered the 752C>A homozy-
gous mutation. Therapy with CDCA was started and the
patient periodically re-evaluated. Tendon xanthomas never
emerged, and diarrhea disappeared. By contrast, ataxia
worsened over time (Fig. 1a). A sharp reduction of choles-
tanol and 7α-hydroxy-4-cholesten-3-one serum levels was
found (Fig. 1b, c), while 27OHC still showed very low
concentrations without substantial changes from baseline.
Brain MRI at 1.5 T was performed every 2 years until the
age of 39 years together with clinical and biochemical
follow-up. At baseline, T2-weighted and FLAIR hyperinten-
sities in the dentate nuclei and surrounding white matter (WM)
were evident. Areas of hypointensity on both T1-weighted
and FLAIR images were found within cerebellar lesions.
Computed tomography, and susceptibility weighted and
T2*-weighted MRI ruled out the presence of calcifications.
Six-year MRI follow-up showed on FLAIR images increase
of the hypointense areas, which replaced hyperintensities
suggesting vacuolation (Fig. 1d). MR spectroscopy (MRS)
on the cerebellar hemispheres (Fig. 2) revealed the following:
i) diffuse decrease of N-acetylaspartate (NAA)/creatine
(Cr)01.58 (n.v. 2.27±0.29) and choline (Cho)/Cr00.53
(n.v. 0.78±0.04), and increased myoinositol (mI)/Cr ratio,
mI/Cr00.43 (n.v. 0.27±0.03) in normal appearing areas; ii)
lactate (Lac) and lipids (Lip) peaks in the voxels of the FLAIR-
hyperintense areas surrounding the FLAIR-hypointense
lesions; and iii) very high Lac and Lip peaks and marked
NAA/Cr decrease in the FLAIR-hypointense lesions.
The serial evaluation of clinical, biochemical and MRI
findings in this patient revealed that CDCA therapy was
effective in decreasing serum levels of bile acids intermedi-
ates and stabilizing systemic manifestations, but failed to
prevent worsening of neurological disturbances and brain
lesions. The lack of correspondence between neurological
and biochemical data is a crucial point, which remains open
to a wide range of interpretations.
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Mechanisms of neurotoxicity in CTX are still unclear and
seem to go beyond the concentration-dependent accumula-
tion of cholestanol. Brain cholestanol may originate from
7α-hydroxylated precursors such as 7α-hydroxy-4-choles-
ten-3-one, which crosses the blood–brain barrier more effi-
ciently and can be converted to cholestanol in neuronal and
glial cells [3]. In our patient, CDCA administration led to
normalization of cholestanol and marked decrease of 7α-
hydroxy-4-cholesten-3-one, whose levels remained slightly
elevated. The role of prolonged exposure to mildly in-
creased serum levels of 7α-hydroxy-4-cholesten-3-one in
neurotoxicity needs further investigation.
The lack of 27OHC could also play a pathogenetic
role. Cerebral 27OHC mostly originates from the circu-
lation and represents an important regulator of choles-
terol metabolism in the brain [4]. In our case, CDCA
was ineffective in restoring plasma 27OHC. Further
studies are warranted to understand if 27OHC deficien-
cy causes an alteration of brain cholesterol homeostasis.
If so, disregulation of the oxysterols may be considered
as a target for new therapies.
The presence of cerebellar hypointensities with “cystic”
appearance on T1-weighted and FLAIR sequences has been
reported in another CTX subject and considered as an un-
usual finding [5]. The cerebellar lesions on FLAIR images
followed over time in our study might represent “two sides
of the same coin”: while hyperintensities are probably the
initial result of abnormal lipid storage, hypointense areas may
be due to cerebellar degeneration caused by cholestanol-
induced apoptosis [6] or by other yet undefined mechanisms
leading to neuroaxonal loss.
MRS findings add relevant metabolic information: the
elevated mI/Cr ratio could be correlated to increased glial
cell population, and both Lac and Lip peaks on the border of
the vacuolating lesions may be the expression of a critical
metabolic condition preceding apoptosis. Their possible utili-
zation as a spectroscopic marker of disease evolution deserves
further studies.
Fig. 1 Six-year clinical, biochemical and brain MRI follow-up. a
International co-operative ataxia rating scale (ICARS) score increases
over time. b Serum cholestanol levels (n.v. 0.34±0.16 mg/dl). c Serum
7α-hydroxy-4-cholesten-3-one levels (n.v. 1.5±0.4 μg/dl). d FLAIR
axial MRI shows increased extension of WM hyperintensities and
hypointense areas, which replace hyperintensities over time
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In conclusion, our serial evaluation in a CTX patient with
progressive ataxia revealed a peculiar MRI pattern, consis-
tent with cerebellar vacuolation, which could be a marker of
poor response to CDCA treatment.
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Fig. 2 Cerebellar MRS imaging performed at age 39 years. a Right
hemisphere: Lip and Lac peaks in the parenchyma surrounding the
FLAIR-hypointense lesion. Left hemisphere: increased Lip and Lac
and decreased NAA peaks in the FLAIR-hypointense lesion. NAA
parametric map: lower (green and blue) and higher (yellow and red)
concentrations. b Right hemisphere: low NAA/Cr in normal appearing
WM; left hemisphere: marked NAA/Cr decrease on FLAIR-
hypointense lesion
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